Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fortress Biotech (FBIO)
NASDAQ:FBIO
Holding FBIO?
Track your performance easily
FBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.36 - $2.89
Previous CloseN/A
Volume489.64K
Average Volume (3M)669.65K
Market Cap
$52.73M
Enterprise Value$7.25M
Total Cash (Recent Filing)$91.68M
Total Debt (Recent Filing)$26.18M
Price to Earnings (P/E)―
Beta2.35
Next Earnings
Mar 27, 2025EPS Estimate
-0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.27
Shares Outstanding27,604,935
10 Day Avg. Volume547,704
30 Day Avg. Volume669,651
Standard Deviation0.21
R-Squared0.18
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.65
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.14
Enterprise Value/Revenue0.09
Enterprise Value/Gross Profit0.13
Enterprise Value/Ebitda-0.09
Forecast
1Y Price Target
$15.00Price Target Upside702.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Fortress Biotech News
PremiumCompany Announcements
Fortress Biotech’s Q3 2024 Earnings and FDA Milestone
Ownership Overview
17.94% Insiders
2.77% Mutual Funds
1.62% Other Institutional Investors
75.27% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FBIO FAQ
What was Fortress Biotech’s price range in the past 12 months?
Fortress Biotech lowest stock price was $1.35 and its highest was $2.89 in the past 12 months.
What is Fortress Biotech’s market cap?
Fortress Biotech’s market cap is $52.73M.
When is Fortress Biotech’s upcoming earnings report date?
Fortress Biotech’s upcoming earnings report date is Mar 27, 2025 which is in 67 days.
How were Fortress Biotech’s earnings last quarter?
Fortress Biotech released its earnings results on Nov 14, 2024. The company reported -$0.76 earnings per share for the quarter, missing the consensus estimate of -$0.595 by -$0.165.
Is Fortress Biotech overvalued?
According to Wall Street analysts Fortress Biotech’s price is currently Undervalued.
Does Fortress Biotech pay dividends?
Fortress Biotech does not currently pay dividends.
What is Fortress Biotech’s EPS estimate?
Fortress Biotech’s EPS estimate is -0.75.
How many shares outstanding does Fortress Biotech have?
Fortress Biotech has 27,604,935 shares outstanding.
What happened to Fortress Biotech’s price movement after its last earnings report?
Fortress Biotech reported an EPS of -$0.76 in its last earnings report, missing expectations of -$0.595. Following the earnings report the stock price went down -8.917%.
Which hedge fund is a major shareholder of Fortress Biotech?
Currently, no hedge funds are holding shares in FBIO
---
Fortress Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.00 (702.14% Upside)
$15.00 (702.14% Upside)
Blogger Sentiment
Bullish
FBIO Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 8.0%
Last 30 Days ▲ 8.0%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.53%
12-Months-Change
Fundamentals
Return on Equity
-256.45%
Trailing 12-Months
Asset Growth
-15.59%
Trailing 12-Months
Company Description
Fortress Biotech
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company. The company was founded on June 28, 2006 in and is headquartered in New York, NY.
---
FBIO Stock 12 Month Forecast
Average Price Target
$15.00
▲(702.14% Upside)
Technical Analysis
Anixa Biosciences
―
Cellectar Biosciences
―
Cyclacel Pharmaceuticals
―
Curis
―
Voyager Therapeutics
―
Best Analysts Covering FBIO
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+3.57%
reiterated a buy rating 2 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +3.57% per trade.
---